A K Sahni1, A Nagendra2, Partha Roy3, S Patrikar4. 1. Professor & Head, Dept of Microbiology, Armed Forces Medical College, Pune 411040, India. 2. Professor & Head (Microbiology), Dr Ulhas Patil Medical College, Jalgaon, India. 3. Associate Professor, Dept of Microbiology, Armed Forces Medical College, Pune 411040, India. 4. Lecturer in Statistics and Demography, Dept of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Abstract
BACKGROUND: Standard HIV testing is done using serum or plasma. FDA approved ELISA to screen urine for IgG antibodies to HIV-1 in 1996. It is a simple, noninvasive test and is appropriate for developing countries where health care personnel may not be professionally trained or where clean needles for drawing blood may not always be available. METHODS: 436 individuals with high-risk behavior and strong clinical suspicion of HIV infection were screened for IgG antibodies to HIV-1 in urine by ELISA. Urine HIV testing was performed by enzyme immunoassay, at the ongoing Voluntary Confidential Counseling and Testing Center (VCCTC) at a large tertiary care microbiology lab. The individuals enrolled for the study had high-risk exposure to the virus and majorities were from a state with a high incidence of HIV infection. In all individuals, both serum and urine were tested for IgG antibodies to HIV-1. RESULTS: Overall, 135 individuals (30.96%) were HIV-positive, of whom 96 (71%) had never previously tested positive; 87% of those who tested positive received their results, and most were referred for medical care. Sensitivity, specificity and predictive values of HIV-1 urine ELISA test kit were determined. Sensitivity was found to be 89.6%; 95% CI [82.9-94.0], specificity 97.3%; 95% CI [94.6-98.8], positive predictive value 93.8%; 95% CI [87.8-97.1] and negative predictive value 95.4%; 95% CI [92.3-97.4]. CONCLUSION: Efficiency, sensitivity, and specificity of the urine-based screening for HIV-1 test kits were excellent as compared to the reference test.
BACKGROUND: Standard HIV testing is done using serum or plasma. FDA approved ELISA to screen urine for IgG antibodies to HIV-1 in 1996. It is a simple, noninvasive test and is appropriate for developing countries where health care personnel may not be professionally trained or where clean needles for drawing blood may not always be available. METHODS: 436 individuals with high-risk behavior and strong clinical suspicion of HIV infection were screened for IgG antibodies to HIV-1 in urine by ELISA. Urine HIV testing was performed by enzyme immunoassay, at the ongoing Voluntary Confidential Counseling and Testing Center (VCCTC) at a large tertiary care microbiology lab. The individuals enrolled for the study had high-risk exposure to the virus and majorities were from a state with a high incidence of HIV infection. In all individuals, both serum and urine were tested for IgG antibodies to HIV-1. RESULTS: Overall, 135 individuals (30.96%) were HIV-positive, of whom 96 (71%) had never previously tested positive; 87% of those who tested positive received their results, and most were referred for medical care. Sensitivity, specificity and predictive values of HIV-1 urine ELISA test kit were determined. Sensitivity was found to be 89.6%; 95% CI [82.9-94.0], specificity 97.3%; 95% CI [94.6-98.8], positive predictive value 93.8%; 95% CI [87.8-97.1] and negative predictive value 95.4%; 95% CI [92.3-97.4]. CONCLUSION: Efficiency, sensitivity, and specificity of the urine-based screening for HIV-1 test kits were excellent as compared to the reference test.
Entities:
Keywords:
Diagnosis of HIV infection; HIV test; Urine testing
Authors: C J Major; S E Read; R A Coates; A Francis; B J McLaughlin; M Millson; F Shepherd; M Fanning; L Calzavara; D MacFadden Journal: J Infect Dis Date: 1991-04 Impact factor: 5.226
Authors: Carol Hilton; Beulah P Sabundayo; Susan J Langan; Martha Hilton; Charlamaine Henson; Thomas C Quinn; Joseph B Margolick; Kenrad E Nelson Journal: J Acquir Immune Defic Syndr Date: 2002-12-01 Impact factor: 3.731
Authors: Fernanda Ludolf; Fernanda F Ramos; Flávia F Bagno; João A Oliveira-da-Silva; Thiago A R Reis; Myron Christodoulides; Paula F Vassallo; Cecilia G Ravetti; Vandack Nobre; Flavio G da Fonseca; Eduardo A F Coelho Journal: Sci Adv Date: 2022-05-13 Impact factor: 14.957